Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
3
2013
Buyer Beware: Important “Supply” Issues For Life Science Companies Sills Cummis & Gross P.C.
Jul
9
2011
The NJ Solar Energy Industry: Boom, Correction And The Future - Part I Sills Cummis & Gross P.C.
Apr
21
2021
New Jersey Appellate Division Finds that Evidence of 510(k) Clearance Cannot be Categorically Excluded in Medical Device Product Liability Cases Sills Cummis & Gross P.C.
Sep
18
2016
In Re Reglan Litigation: New Jersey Supreme Court Holds that Failure to Timely Update Claims against Generic Drug Manufacturers Are Not Pre-Empted by Federal Law Sills Cummis & Gross P.C.
Mar
17
2014
Letters Of Intent For On-Site Solar Energy Transactions Sills Cummis & Gross P.C.
Apr
29
2020
Pharmacy Groups Request COVID-19 Testing Authority for California Pharmacists Much Shelist, P.C.
Dec
6
2017
DEA Relaxes Requirements for Use of Automated Dispensing Systems in Long-Term Care Facilities — Is Illinois Next? Much Shelist, P.C.
Sep
16
2015
New Business Opportunities for Pharmacies: Do You Have the Required Licenses? Much Shelist, P.C.
Oct
8
2015
Medical Cannabis in Illinois: What Health Care Providers and Organizations Need to Know Much Shelist, P.C.
Oct
22
2015
Medical Cannabis in Illinois: What Employers Need to Know Much Shelist, P.C.
Mar
5
2019
2018 Farm Bill Legalizes Hemp, but Obstacles to Sale of CBD Products Remain Much Shelist, P.C.
Feb
4
2020
Will the Coronavirus Make Your Business Sick? Much Shelist, P.C.
Apr
20
2020
DEA Provides Three Exceptions to Key Regulations Addressing the Treatment of Controlled Substances at Hospitals and Clinics Much Shelist, P.C.
Aug
22
2013
Coming Clean: EPA Finally Adopts Industrial Wipes Standard Much Shelist, P.C.
Apr
20
2020
Pharmacists Authorized to Order and Administer COVID-19 Testing Much Shelist, P.C.
Mar
6
2018
Drug Testing an Employee Who Reports a Work-Related Accident? Special Rules Apply Much Shelist, P.C.
Apr
19
2019
FDA Update: Recent Trends and a New Regime Sheppard, Mullin, Richter & Hampton LLP
Nov
3
2014
Agricultural Cooperative Antitrust Litigation Continues to Mushroom Sheppard, Mullin, Richter & Hampton LLP
Jan
5
2015
New FDA Draft Guidance on REMS and Bioequivalence Studies: Does New Procedure Secure ANDA Applicants The Right to Obtain Samples? Sheppard, Mullin, Richter & Hampton LLP
Oct
5
2021
California Jury Awards Millions to Cannabis Company in Antitrust Case Sheppard, Mullin, Richter & Hampton LLP
Nov
1
2021
Florida Imposes Criminal Penalties for Improper Processing of DNA Sheppard, Mullin, Richter & Hampton LLP
Dec
10
2021
CMS Suspends Vaccine Mandate Enforcement for Healthcare Workers Sheppard, Mullin, Richter & Hampton LLP
Jan
3
2022
Healthcare Res. Mgmt. Grp., LLC v. Econatura All Healthy World, LLC – A Cautionary Tale: Meticulous or Careless Strategy Required to Prove Your Trade Secret Claim Sheppard, Mullin, Richter & Hampton LLP
Mar
24
2022
New York Regulators to Jumpstart NY’s Cannabis Industry by Giving Priority to Small Businesses and Individuals with Prior Cannabis Convictions Sheppard, Mullin, Richter & Hampton LLP
Jan
14
2020
Day 1 Notes at the 2020 J.P. Morgan Healthcare Conference Sheppard, Mullin, Richter & Hampton LLP
Jun
13
2022
French Insider Podcast Episode 14: French Investments in the U.S. Wine Industry [PODCAST] Sheppard, Mullin, Richter & Hampton LLP
Feb
28
2020
Federal Circuit Changes the Game for Selling Single-API Drugs to the Government Sheppard, Mullin, Richter & Hampton LLP
Aug
3
2022
The Government Seeks FCA Liability for Off-Label Use of Medical Devices Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins